{"SLR NAME":"Effects of COVID-19 pandemic on out-of-hospital cardiac arrest: a systematic review and meta-analysis","References":[{"title1":"COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests","References":[{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Covid-19:navigating the uncharted","References":[{"title3":"Center for Infectious Disease Research and Policy. Global COVID rise continues; 50 nations report B117 variant. Available from URL: https://www.cidrap.umn.edu/news-perspective/2021/01/global-covid-rise-continues-50-nations-report-b117-variant (accessed February 2021)."},{"title3":"COVID-19 vaccines: breaking record times to first-in-human trials"},{"title3":"The Harvard Gazette. Fauci says herd immunity possible by fall, 'normality' by end of 2021. Available from URL: https://news.harvard.edu/gazette/story/2020/12/anthony-fauci-offers-a-timeline-for-ending-covid-19-pandemic (accessed February 2021)."},{"title3":"Anesthesia Patient Safety Foundation. Protecting our Patients: APSF Recommends that Anesthesia Professionals be Included in the First Phase of Vaccinations. Available from URL: https://www.apsf.org/news-updates/protecting-our-patients-apsf-recommends-that-anesthesia-professionals-be-included-in-the-first-phase-of-vaccinations (accessed February 2021)."},{"title3":"When, where, and how do immunizations fail?"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Coronavirus disease 2019 (COVID-19) in Italy","References":[{"title3":"The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: Early data from a single-institute survey"},{"title3":"Coronavirus Disease-2019 in cancer patients. A report of the first 25 cancer patients in a Western country (Italy)"},{"title3":"Cancer patients with COVID-19: a retrospective study of 51 patients in the district of Piacenza, Northern Italy"},{"title3":"Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates"},{"title3":"Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!"}]},{"title2":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","References":[]},{"title2":"Out-of-hospital cardiac arrest during the COVID-19 pandemic in Italy","References":[{"title3":"Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy"},{"title3":"Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study"},{"title3":"The other side of novel coronavirus outbreak: fear of performing cardiopulmonary resuscitation"},{"title3":"Prevalence of COVID-19 in out-of-hospital cardiac arrest: implications for bystander CPR"},{"title3":"COVID-19 - Mobility Trends Reports - Apple. (Accessed 16 June 2020, at https://www.apple.com/covid19/mobility/)."}]},{"title2":"Cardiac arrest and cardiopulmonary resuscitation outcome reports: Update of the Utstein Resuscitation Registry Templates for out-of-hospital cardiac arrest: a statement for healthcare professionals from a Task Force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, Interamerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia); and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation","References":[]},{"title2":"Protezione Civile National Department Repository. http://opendatadpc.maps.arcgis.com/apps/opsdashboard/index.html#/b0c68bce2cce478eaac82fe38d4138b1.","References":[]},{"title2":"Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology","References":[]},{"title2":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","References":[{"title3":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation"},{"title3":"Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial"},{"title3":"Outcomes 1 year after thrombus aspiration for myocardial infarction"},{"title3":"Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: thrombectomy trialists collaboration"},{"title3":"Impact of multivessel coronary artery disease and noninfarct-related artery revascularization on outcome of patients with ST-elevation myocardial infarction transferred for primary percutaneous coronary intervention (from the EUROTRANSFER registry)"},{"title3":"Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction"},{"title3":"Fractional flow reserve-guided multivessel angioplasty in myocardial infarction"},{"title3":"Randomized trial of preventive angioplasty in myocardial infarction"},{"title3":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial"},{"title3":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial"},{"title3":"Complete versus culprit-only revascularization for ST-segment-elevation myocardial infarction and multivessel disease: a meta-analysis and trial sequential analysis of randomized trials"},{"title3":"Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials"},{"title3":"Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)"},{"title3":"Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease"},{"title3":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock"},{"title3":"Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial"},{"title3":"Prehospital ticagrelor in ST-segment elevation myocardial infarction"},{"title3":"Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting"},{"title3":"Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study"},{"title3":"Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention"},{"title3":"Early intravenous beta-blockers in patients with ST-segment elevation myocardial infarction before primary percutaneous coronary intervention"},{"title3":"Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function"}]},{"title2":"The REDCap consortium: building an international community of software platform partners","References":[{"title3":"Clinical research informatics: survey of recent advances and trends in a maturing field"},{"title3":"Advancing methodologies in Clinical Research Informatics (CRI): Foundational work for a maturing field"},{"title3":"Clinical research informatics: a conceptual perspective"},{"title3":"Obstacles facing translational research in academic medical centers"},{"title3":"Central challenges facing the national clinical research enterprise"},{"title3":"The Role of Technology in Translational Science"},{"title3":"Crossing the chasm: information technology to biomedical informatics"},{"title3":"Can small institutes address some problems facing biomedical researchers?"},{"title3":"Practice-Based Innovations: More Relevant and Transportable Than NIH-funded Studies"},{"title3":"Clinical research at a crossroads: the NIH roadmap"},{"title3":"NIH Career Development Awards in Clinical and Translational Science Award Institutions: Distinguishing Characteristics of Top Performing Sites"},{"title3":"Launching PCORnet, a national patient-centered clinical research network"},{"title3":"Academic Medical Product Development: An Emerging Alliance of Technology Transfer Organizations and the CTSA"},{"title3":"Designing a Public Square for Research Computing"},{"title3":"Reengineering the national clinical and translational research enterprise: the strategic plan of the National Clinical and Translational Science Awards Consortium"},{"title3":"Organizational assimilation of complex technologies: an empirical study of component-based software development"},{"title3":"Global Software Development and Collaboration: Barriers and Solutions"},{"title3":"Barriers to adoption of software reuse: A qualitative study"},{"title3":"A Qualitative Model for Barriers to Software Reuse Adoption"},{"title3":"Software Licensing in the 21st Century: Are Software Licenses Really Sales, and How Will the Software Industry Respond"},{"title3":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support"},{"title3":"Cerebrospinal Fluid and Plasma (1 3)-beta-d-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental Hematogenous Candida Meningoencephalitis, Antimicrob"},{"title3":"(A)musicality in Williams syndrome: examining relationships among auditory perception, musical skill, and emotional responsiveness to music"},{"title3":"Peer Network Counseling with Urban Adolescents: A Randomized Controlled Trial with Moderate Substance Users"},{"title3":"A Randomized Trial of Phototherapy with Filtered Sunlight in African Neonates"},{"title3":"Construction and management of ARDS/sepsis registry with REDCap"},{"title3":"Glocal clinical registries: pacemaker registry design and implementation for global and local integration--methodology and case study"},{"title3":"Clinical Case Registries: simultaneous local and national disease registries for population quality management"},{"title3":"Dispelling myths about rare disease registry system development"},{"title3":"Pediatric Acute Lung Injury and Sepsis Investigator's Network and the National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, Critically ill children during the 2009-2010 influenza pandemic in the United States"},{"title3":"A brief, low-cost intervention improves the quality of ambulatory gastroenterology consultation notes"},{"title3":"A framework for evaluating the appropriateness of clinical decision support alerts and responses"},{"title3":"The initial response to the Boston marathon bombing: lessons learned to prepare for the next disaster"},{"title3":"A comparative effectiveness trial of postoperative management for lumbar spine surgery: changing behavior through physical therapy (CBPT) study protocol"},{"title3":"A Comparison of Criterion Standard Methods to Diagnose Acute Heart Failure"},{"title3":"A method for comparing and combining cost-of-illness studies: an example from cardiovascular disease"},{"title3":"A Comparison of Self-Esteem and Perfectionism in Anorexia Nervosa and Body Dysmorphic Disorder"},{"title3":"A feasibility study to evaluate breast cancer patients' knowledge of their diagnosis and treatment"},{"title3":"User Satisfaction With Telehealth: Study of Patients, Providers, and Coordinators"},{"title3":"Leveraging Electronic Tablets and a Readily Available Data Capture Platform to Assess Chronic Pain in Children: The PROBE system"},{"title3":"The use of Research Electronic Data Capture (REDCap) software to create a database of librarian-mediated literature searches"},{"title3":"The process of installing REDCap, a web based database supporting biomedical research: the first year"},{"title3":"Eulogy for the clinical research center"},{"title3":"Procurement of shared data instruments for Research Electronic Data Capture (REDCap)"},{"title3":"Using the PhenX Toolkit to Add Standard Measures to a Study"},{"title3":"PhenX RISING network, PhenX RISING: real world implementation and sharing of PhenX measures"},{"title3":"BioPortal: enhanced functionality via new Web services from the National Center for Biomedical Ontology to access and use ontologies in software applications"},{"title3":"Patient-Reported Outcomes Measurement Information System (PROMIS ): Efficient, Standardized Tools to Measure Self-Reported Health and Quality of Life"},{"title3":"An i2b2-based, generalizable, open source, self-scaling chronic disease registry"},{"title3":"Global Medical Records System Collaborative: Factors Influencing Successful Implementation"}]},{"title2":"Research electronic data capture (REDCap):a metadata-driven methodology and workflow process for providing translational research informatics support","References":[{"title3":"A New Vision for the National Institutes of Health"},{"title3":"SQLGEN: a framework for rapid client-server database application development"},{"title3":"WebEAV: automatic metadata-driven generation of web interfaces to entity-attribute-value databases"},{"title3":"Model-driven development of Web applications: the Auto Web system"},{"title3":"Value of Hosted Clinical Data Environments"},{"title3":"A comparison study: paper-based versus web-based data collection and management"}]},{"title2":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Factors associated with pulseless electric activity versus ventricular fibrillation: the Oregon Sudden Unexpected Death Study","References":[]},{"title2":"Prevention of deterioration of ventricular fibrillation by basic life support during out-of-hospital cardiac arrest","References":[]},{"title2":"Rapid Progression to acute respiratory distress syndrome: review of current understanding of critical illness from COVID-19 infection","References":[]},{"title2":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","References":[]},{"title2":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response","References":[]},{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","References":[]},{"title2":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health: the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Coronavirus infections: more than just the common cold"},{"title3":"Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020. http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":" Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Published March 13, 2020. Accessed January 28, 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected"},{"title3":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (covid-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"A Novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"}]},{"title2":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease","References":[{"title3":"Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management"},{"title3":"Acute and Chronic Effects of COVID-19 on the Cardiovascular System"},{"title3":"Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials"},{"title3":"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic"},{"title3":"Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19"},{"title3":"COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment"},{"title3":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China"},{"title3":"A case-control, multicentre study of consecutive patients with COVID-19 and acute (myo)pericarditis: incidence, risk factors, clinical characteristics and outcomes"},{"title3":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)"},{"title3":"Myocardial Injury in COVID-19 Patients: Association with Inflammation, Coagulopathy and In-Hospital Prognosis"},{"title3":"Mid-term effects of SARS-CoV-2 infection on cardiovascular outcomes"},{"title3":"Long-term cardiovascular outcomes of COVID-19"},{"title3":"Values and pitfalls of the use of administrative databases for outcomes assessment"},{"title3":"Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol"},{"title3":"Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document"},{"title3":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium"},{"title3":"Validation of a combined comorbidity index"},{"title3":"Variable selection strategies and its importance in clinical prediction modelling"},{"title3":"Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study"},{"title3":"Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry"},{"title3":"Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study"},{"title3":"Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk"},{"title3":"Long-Term Outcomes of Patients with Coronavirus Disease 2019 at One Year after Hospital Discharge"},{"title3":"Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes"},{"title3":"Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation"},{"title3":"Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19"},{"title3":"Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination"},{"title3":"Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System"}]},{"title2":"Cardiac and arrhythmic complications in patients with COVID-19","References":[{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China"},{"title3":"Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin"},{"title3":"The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection"},{"title3":"An experimental model for dilated cardiomyopathy after rabbit coronavirus infection"},{"title3":"Coronaviruses and the cardiovascular system: acute and long-term implications"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS)"},{"title3":"Cardiac arrest in severe acute respiratory syndrome: analysis of 15 cases"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV)-worldwide, 2012-2013"},{"title3":"Vaccines for emerging infectious diseases: lessons from MERS coronavirus and Zika virus"},{"title3":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Acute myocarditis associated with novel Middle East respiratory syndrome coronavirus"},{"title3":"Seasonal influenza infections and cardiovascular disease mortality"},{"title3":"Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators"},{"title3":"Influenza-associated hospitalizations for cardiovascular diseases in the tropics"},{"title3":"Influenza vaccine in heart failure"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study"},{"title3":"Frequency of troponin elevations in patients with influenza infection during the 2017-2018 influenza season"},{"title3":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SAR"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Human immunopathogenesis of severe acute respiratory syndrome (SARS)"},{"title3":"An acute respiratory infection runs into the most common noncommunicable epidemic:COVID-19 and cardiovascular diseases"},{"title3":"Chloroquine-induced cardiomyopathy"},{"title3":"Ventricular tachycardia in a patient on dehydroemetine and chloroquine for amoebic liver abscess"},{"title3":"Drug-induced ventricular tachycardia"},{"title3":"Chloroquine and cardiac arrhythmia: case report"},{"title3":"Antiarrhythmic potential of chloroquine: new use for an old drug"},{"title3":"Heart conduction disorders in long-term treatment with chloroquine: two new cases"},{"title3":"Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current if: novel electrophysiological insights and therapeutic potential"},{"title3":"Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"}]},{"title2":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","References":[{"title3":"Letter to the editor about &quot;Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial&quot;"},{"title3":"Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China"},{"title3":"European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 - first update. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidance-discharge-and-ending-isolation-first%20update.pdf (Accessed 4 October, 2020)."},{"title3":"Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis"},{"title3":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial"}]},{"title2":"Inpatient use of ambulatory telemetry monitors for COVID-19 patients treated with hydroxychloroquine and/or azithromycin","References":[]},{"title2":"Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation","References":[{"title3":"Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function"},{"title3":"The varying faces of IL-6: From cardiac protection to cardiac failure"},{"title3":"The paradigm of IL-6: from basic science to medicine"},{"title3":"Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling"},{"title3":"Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes"},{"title3":"Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis"},{"title3":"Long QT Syndrome: An Emerging Role for Inflammation and Immunity"},{"title3":"Prognostic electrocardiographic parameters in patients with suspected myocarditis"},{"title3":"Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation"},{"title3":"Inflammation and prolonged QT time: results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) study"},{"title3":"Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England"},{"title3":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study"},{"title3":"Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis"},{"title3":"Population-based study of QT interval prolongation in patients with rheumatoid arthritis"},{"title3":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis"},{"title3":"Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation"},{"title3":"Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden"},{"title3":"Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative"},{"title3":"Elevated IL-1beta levels in anti-Ro/SSA connective tissue diseases patients with prolonged corrected QTc interval"},{"title3":"hERG 1a LQT2 C-terminus truncation mutants display hERG 1b-dependent dominant negative mechanisms"},{"title3":"Molecular biology of K(+) channels and their role in cardiac arrhythmias"},{"title3":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias"},{"title3":"Role of pharmacotherapy in cardiac ion channelopathies"},{"title3":"The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy"},{"title3":"Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator"},{"title3":"TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation"},{"title3":"Tumor necrosis factor-alpha downregulates the voltage gated outward K+ current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts"},{"title3":"Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells"},{"title3":"Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha"},{"title3":"Macrophage-dependent IL-1beta production induces cardiac arrhythmias in diabetic mice"},{"title3":"SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes"},{"title3":"LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms"},{"title3":"Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome"},{"title3":"High-fat diet-dependent modulation of the delayed rectifier K(+) current in adult guinea pig atrial myocytes"},{"title3":"Characterization of hERG1a and hERG1b potassium channels-a possible role for hERG1b in the I (Kr) current"},{"title3":"State-dependent blockade of human ether-a-go-go-related gene (hERG) K(+) channels by changrolin in stably transfected HEK293 cells"},{"title3":"hERG potassium channel gating is mediated by N- and C-terminal region interactions"},{"title3":"A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling"},{"title3":"Rapid component I(Kr) of the guinea-pig cardiac delayed rectifier K(+) current is inhibited by beta(1)-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways"},{"title3":"Role of JAK-STAT pathway in reducing cardiomyocytes hypoxia/reoxygenation injury induced by S1P postconditioning"},{"title3":"Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes"},{"title3":"Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1alpha-VEGF mediated angiogenesis"},{"title3":"Review: The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways"},{"title3":"Ventricular K+ currents are reduced in mice with elevated levels of serum TNFalpha"},{"title3":"TNFalpha Modulates Cardiac Conduction by Altering Electrical Coupling between Myocytes"},{"title3":"Calcium-dependent arrhythmias in transgenic mice with heart failure"},{"title3":"The role of interleukin-6 in the failing heart"},{"title3":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis"},{"title3":"Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis"},{"title3":"Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights"},{"title3":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial"}]},{"title2":"The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection","References":[{"title3":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread."},{"title3":"In Vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."},{"title3":"An algorithm for managing QT prolongation in Coronavirus Disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine."},{"title3":"Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding."},{"title3":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan."},{"title3":"Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS."},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus."},{"title3":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study."},{"title3":"Asians do not exhibit elevated expression or unique genetic polymorphisms for ACE2, the cell-entry receptor of SARS-CoV-2."},{"title3":"A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19)."},{"title3":"Epidemiology of symptomatic drug-induced long QT syndrome and Torsade de Pointes in Germany."},{"title3":"Predicting drug-induced QT prolongation and torsades de pointes."},{"title3":"Hypomagnesemia and hypermagnesemia."},{"title3":"Long QT syndrome and sinus bradycardia-a mini review."},{"title3":"High prevalence of the risk factors for QT interval prolongation and associated drug-drug interactions in coronary care units."},{"title3":"Taking the &quot;idio&quot; out of &quot;idiosyncratic&quot;: predicting torsades de pointes."},{"title3":"Drug-induced sudden death."},{"title3":"Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome."},{"title3":"Quinidine syncope. Paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias."},{"title3":"Prolonged QT interval with halofantrine."},{"title3":"Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base."},{"title3":"Cardiotoxicity of antimalarial drugs."},{"title3":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia."},{"title3":"Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus."},{"title3":"Hydroxychloroquine; a poorly recognized problem in rheumatology patients."},{"title3":"Which QT correction formulae to use for QT Monitoring?"},{"title3":"A case of QT-interval prolongation precipitated by azithromycin."},{"title3":"QT prolongation associated with azithromycin/amiodarone combination."},{"title3":"Azithromycin-induced QT prolongation in elderly patient."},{"title3":"[Torsade de pointes and cardiorespiratory arrest induced by azithromycin in a patient with congenital long QT syndrome]."},{"title3":"Azithromycin as a cause of QT-interval prolongation and torsade de pointes in the absence of other known precipitating factors."},{"title3":"Azithromycin-induced torsade de pointes."},{"title3":"Polymorphic ventricular tachycardia with a normal QT interval following azithromycin."},{"title3":"Azithromycin and the risk of cardiovascular death."},{"title3":"Azithromycin causes a novel proarrhythmic syndrome."},{"title3":"Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy."}]},{"title2":"QT interval prolongation as predictor of sudden death in patients with myocardial infarction","References":[]},{"title2":"QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest","References":[]},{"title2":"Risk stratification for sudden cardiac death: current status and challenges for the future","References":[{"title3":"Executive Summary: Heart Disease and Stroke Statistics-2013 Update. A report from the American Heart Association"},{"title3":"Cardiovascular disease in Europe: epidemiological update"},{"title3":"Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980-2009"},{"title3":"The (possibly) deceptive figures of decreased coronary heart disease mortality in Europe"},{"title3":"Estimating deaths from cardiovascular disease. A review of global methodologies of mortality measurement"},{"title3":"Sudden cardiac death: structure, function, and time dependence of risk"},{"title3":"Out-of-Hospital cardiac arrest in the 1990's. A population based study in the Maastricht area on incidence, characteristics and survival"},{"title3":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon sudden unexpected death study"},{"title3":"Framingham risk score and prediction of life time risk for coronary artery disease"},{"title3":"The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy and policy issues: a report from the American College of Cardiology"},{"title3":"Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the seven countries study"},{"title3":"European guidelines on cardiovascular disease prevention in clinical practice (version 2012)"},{"title3":"Agreement among cardiovascular disease risk calculators"},{"title3":"Primary prevention of cardiovascular disease using validated risk scores: a systematic review"},{"title3":"The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study"},{"title3":"Emerging biomarkers in heart failure"},{"title3":"Sudden cardiac death caused by coronary heart disease"},{"title3":"Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease"},{"title3":"Heart rate profile during exercise as a predictor of sudden death"},{"title3":"Relation of heart rate at rest and long-term (&gt;20 years) death rate in initially healthy middle-aged men"},{"title3":"Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population"},{"title3":"Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry"},{"title3":"Prolonged QTc interval and risks of total and cardiovascular mortality and sudden death in the general population. A review and qualitative overview of the prospective cohort studies"},{"title3":"Prolonged QTc interval and risk of sudden cardiac death in a population of older adults"},{"title3":"Prolonged Tpeak-to-Tend interval on the resting ECG is associated with increased risk of sudden cardiac death"},{"title3":"Long-term outcome associated with early repolarization on electrocardiography"},{"title3":"Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in general population"},{"title3":"Prevalence and prognostic significance of T-Wave inversions in right precordial leads of a 12-lead electrocardiogram in the middle-aged subjects"},{"title3":"QRS-T angle as a predictor of sudden cardiac death in a middle-aged general population"},{"title3":"Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk)"},{"title3":"Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era"},{"title3":"Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death"},{"title3":"Attenuated recovery of heart rate turbulence early after myocardial infarction identifies patients at high risk for fatal or near-fatal arrhythmic events"},{"title3":"Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction"},{"title3":"The long QT syndrome: prospective longitudinal study of 328 families"},{"title3":"Phenotypic variability and unusual clinical severity of congenital long QT syndrome in a founder population"},{"title3":"Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies"},{"title3":"Diabetic autonomic imbalance and glycemic variability"},{"title3":"Defective cardiac parasympathetic control in patients with heart disease"},{"title3":"Reflex and tonic autonomic markers for risk stratification in patients with type 2 diabetes surviving acute myocardial infarction"},{"title3":"Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction"},{"title3":"Neural activity and ventricular fibrillation"},{"title3":"Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification"},{"title3":"Sympathetic innervation, denervation, and cardiac arrhythmias"},{"title3":"Baroreflex sensitivity"},{"title3":"Spontaneous baroreflex sensitivity: prospective validation trial of a novel technique in survivors of acute myocardial infarction"},{"title3":"Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death"},{"title3":"Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction"},{"title3":"Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias. Implications for clinical trials"},{"title3":"Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era"},{"title3":"Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology Consensus"},{"title3":"Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study"},{"title3":"Heart rate recovery immediately after exercise as a predictor of mortality"},{"title3":"Prognostic value of late heart rate recovery after treadmill exercise"},{"title3":"Assessment of autonomic function in humans by heart rate spectral analysis"},{"title3":"Power spectrum analysis of heart rate variability to assess the changes in sympatho-vagal balance during graded orthostatic tilt"},{"title3":"Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function"},{"title3":"Prevalent low-frequency oscillation of heart rate: novel predictor of mortality after myocardial infarction"},{"title3":"Heart rate variability, sleep and sleep disorders"},{"title3":"Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients"},{"title3":"Autonomic tests to detect cardiac risk and their clinical practicality"},{"title3":"Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome"},{"title3":"Rapid heart rate increase at onset of exercise predicts adverse cardiac events in patients with coronary artery disease"},{"title3":"Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction"},{"title3":"Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy"},{"title3":"RT variability unrelated to heart period and respiration progressively increases during graded head-up tilt"},{"title3":"Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction"},{"title3":"Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1"},{"title3":"Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome"},{"title3":"Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients"},{"title3":"Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community"},{"title3":"Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: too little and too late?"},{"title3":"Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry"},{"title3":"Extended mortality benefit of early postinfarction reperfusion. GUSTO-I Angiographic Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries trial"},{"title3":"Effect of candesartan on cause-specific mortality in heart failure patients. The Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) Program"},{"title3":"Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction"},{"title3":"Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?"},{"title3":"Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both"},{"title3":"Post-mortem cardiac 3-T magnetic resonance imaging visualization of sudden cardiac death?"},{"title3":"Acute coronary findings at autopsy in heart failure patients with sudden death. Results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial"},{"title3":"Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)"},{"title3":"Sudden cardiac death in heart failure patients with preserved ejection fraction"},{"title3":"Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients"},{"title3":"How do patients with heart failure with preserved ejection fraction die?"},{"title3":"Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial"},{"title3":"Incidence and predictors of sudden cardiac death in patients with diastolic heart failure"},{"title3":"Mode of death in patients with heart failure and a preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction study (I-Preserve) trial"},{"title3":"Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort stud"},{"title3":"Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials"},{"title3":"Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease. Lessons from the MUSTT study"},{"title3":"The Seattle Heart Failure Model: prediction of survival in heart failure"},{"title3":"Prediction of mode of death in heart failure: the Seattle Heart Failure Model"},{"title3":"B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction"},{"title3":"Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis"},{"title3":"N-terminal pro-B-type natruiuretic peptide is a major predictor of appropriate ICD therapy"},{"title3":"Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction"},{"title3":"Common variants at SCN5A/SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death"},{"title3":"Sudden cardiac death, founder populations and mushrooms. What is the link with gold mines and modifier genes?"},{"title3":"Impact of genetics on the clinical management of channelopathies"},{"title3":"NOS1AP is a genetic modifier of the long-QT syndrome"},{"title3":"Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner"},{"title3":"Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in the long QT syndrome"},{"title3":"Sudden cardiac death"},{"title3":"Family history as a risk factor for primary cardiac arrest"},{"title3":"Predicting sudden death in the population: the Paris Prospective Study I"},{"title3":"Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients"},{"title3":"Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event"},{"title3":"Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death"},{"title3":"Sudden cardiac death, genes, and arrhythmogenesis. Consideration of new population and mechanistic approaches from a National Heart, Lung, Blood Institute workshop. Part I"},{"title3":"Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction"},{"title3":"Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals"},{"title3":"Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest"},{"title3":"GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease"},{"title3":"Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description"},{"title3":"Genome-wide association of implantable cardioverter-defibrillator activation with life-threatening arrhythmias"},{"title3":"Polymorphisms associated with ventricular tachyarrhythmias: rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study"},{"title3":"Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study"},{"title3":"Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future"},{"title3":"Indications for implantable cardioverter-defibrillators based on evidence and judgment"},{"title3":"Cardiac arrest outside of a hospital: how can we improve results of resuscitation?"}]},{"title2":"Digestive symptoms in COVID-19 patients with mild disease severity","References":[{"title3":"Persons evaluated for 2019 novel coronavirus - United States, January 2020"},{"title3":"RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak"},{"title3":"Evidence for gastrointestinal infection of SARS-CoV-2"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission"},{"title3":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"ACE2 angiotensin I converting enzyme 2 [Homo sapiens (human)]. Gene ID: 59272"},{"title3":"COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)"},{"title3":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Caution on Kidney Dysfunctions of 2019-nCoV patients"}]},{"title2":"COVID-19, arrhythmic risk and inflammation: mind the gap!","References":[]},{"title2":"Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence","References":[]},{"title2":"Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"COVID-19 in Europe: the Italian lesson."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Government of Italy decree of the president of the Council of Ministers 9 March 2020 (). (In Italian.)"},{"title3":"L'andamento dei decessi del 2020. Dati anticipatori sulla base del sistema ANPR. Istat, March 31, 2020 (). (In Italian.)"}]},{"title2":"Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiologia intervencionista en Espana","References":[]},{"title2":"Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic","References":[{"title3":"Coronavirus Disease 2019 (COVID-19)"},{"title3":"2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines"},{"title3":"Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC's Interventional Council and SCAI"},{"title3":"Impacto de la pandemia de COVID-19 sobre la actividad asistencial en cardiologia ntervencionista en Espana"},{"title3":"Acute myocardial infarction after laboratory-confirmed influenza infection"}]},{"title2":"Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials","References":[]},{"title2":"Covid-19:the law and limits of quarantine","References":[]},{"title2":"Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period","References":[{"title3":"World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report - 66 (WHO, 2020); https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200326-sitrep-66-covid-19.pdf?sfvrsn=9e5b8b48_2."},{"title3":"&quot;'Not a wave, a tsunami.' Italy hospitals at virus limit,&quot; AP NEWS, 13 March 2020; https://apnews.com/a4497f31bf5dbc1ff263e4263fc9f69e."},{"title3":"&quot;COVID-19 infections rise in New York with peak weeks away.&quot; AP NEWS, 25 March 2020; https://apnews.com/7c7563cb82626a4042797c6aa6da260a."},{"title3":"SARS legacy: Outbreak reporting is expected and respected"},{"title3":"Centers for Disease Control and Prevention, Transcript for the CDC Telebriefing Update on COVID-19 (CDC, 2020); https://www.cdc.gov/media/releases/2020/t0225-cdc-telebriefing-covid-19.html."},{"title3":"The antigenic evolution of influenza: Drift or thrift?"},{"title3":"Complete genomic sequence of human coronavirus OC43: Molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event"},{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Human coronavirus circulation in the United States 2014-2017"},{"title3":"Potential impact of seasonal forcing on a SARS-CoV-2 pandemic"},{"title3":"Absolute humidity and the seasonal onset of influenza in the continental United States"},{"title3":"Absolute humidity and pandemic versus epidemic influenza"},{"title3":"Conjunction of factors triggering waves of seasonal influenza"},{"title3":"The time course of the immune response to experimental coronavirus infection of man"},{"title3":"Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests"},{"title3":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus"},{"title3":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing"},{"title3":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?"},{"title3":"N. Thakkar, R. Burstein, H. Hu, P. Selvaraj, D. Klein, Institute for Disease Modeling, Bill &amp; Melinda Gates Foundation, Social distancing and mobility reductions have reduced COVID-19 transmission in King County, WA (Institute for Disease Modeling, 2020); https://covid.idmod.org/data/Social_distancing_mobility_reductions_reduced_COVID_Seattle.pdf."},{"title3":"N. M. Ferguson, D. Laydon, G. Nedjati-Gilani, N. Imai, K. Ainslie, M. Baguelin, S. Bhatia, A. Boonyasiri, Z. Cucunuba, G. Cuomo-Dannenburg, A. Dighe, H. Fu, K. Gaythorpe, H. Thompson, R. Verity, E. Volz, H. Wang, Y. Wang, P. G. Walker, C. Walters, P. Winskill, C. Whittaker, C. A. Donnelly, S. Riley, A. C. Ghani, Impact of non-pharmaceutical interventions (NPIs) to reduce COVID- 19 mortality and healthcare demand (Imperial College COVID-19 Response Team, 2020); https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-NPI-modelling-16-03-2020.pdf."},{"title3":"&quot;Coronavirus: Thousands of extra hospital beds and staff,&quot; BBC News, 21 March 2020; https://www.bbc.com/news/uk-51989183."},{"title3":"Makeshift hospitals for COVID-19 patients: Where health-care workers and patients need sufficient ventilation for more protection"},{"title3":"&quot;Pentagon says it will give 5 million respirators, 2,000 ventilators to Health and Human Services for virus response,&quot; AP NEWS, 17 March 2020; https://apnews.com/79e98812b5b1592a134803b00c8d88b0."},{"title3":"&quot;Coronavirus: How can China build a hospital so quickly?&quot; BBC News, 31 January 2020; https://www.bbc.com/news/world-asia-china-51245156."},{"title3":"Centers for Disease Control and Prevention, The National Respiratory and Enteric Virus Surveillance System (NREVSS) (CDC, 2020); https://www.cdc.gov/surveillance/nrevss/index.html."},{"title3":"Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: A statistical method"},{"title3":"Centers for Disease Control and Prevention, FluView Interactive (CDC, 2018); https://www.cdc.gov/flu/weekly/fluviewinteractive.htm."},{"title3":"Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures"},{"title3":"How generation intervals shape the relationship between growth rates and reproductive numbers"},{"title3":"Driving factors of influenza transmission in the Netherlands"},{"title3":"The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application"},{"title3":"Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: A statistical analysis of publicly available case data"},{"title3":"World Health Organization, Coronavirus Disease 2019 (COVID-19) Situation Report - 51 (WHO, 2020); www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10."},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"What is the best control strategy for multiple infectious disease outbreaks?"},{"title3":"Public health interventions and epidemic intensity during the 1918 influenza pandemic"},{"title3":"The US 2009 A(H1N1) influenza epidemic: Quantifying the impact of school openings on the reproductive number"},{"title3":"James Cook University, State of the Tropics 2017 Report: Sustainable Infrastructure in the Tropics (James Cook University, 2017); https://www.jcu.edu.au/state-of-the-tropics/publications/2017."},{"title3":"Global spatio-temporal patterns of influenza in the post-pandemic era"},{"title3":"Demonstrating vaccine effectiveness during a waning epidemic: A WHO/NIH meeting report on approaches to development and licensure of Zika vaccine candidates"},{"title3":"Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)"},{"title3":"Is COVID-19 receiving ADE from other coronaviruses?"},{"title3":"Understanding SARS-CoV-2-mediated inflammatory responses: From mechanisms to potential therapeutic tools"},{"title3":"The effect of human mobility and control measures on the COVID-19 epidemic in China"},{"title3":"Influenza seasonality: Lifting the fog"},{"title3":"Ten weeks to crush the curve"},{"title3":"C. Tedijanto, c2-d2/CoV-seasonality: First release, Zenodo (2020); https://zenodo.org/record/3726085#.XpC68_7twwk."},{"title3":"S. Kissler, nCoV_introduction, Version 4.0, Zenodo (2020); https://zenodo.org/record/3745557#.XpC7Y_7twwk."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Comparison of three methods for selecting values of input variables in the analysis of output from a computer code"},{"title3":"Characterizing the reproduction number of epidemics with early subexponential growth dynamics"},{"title3":"R Core Team, R: A language and environment for statistical computing (R Foundation for Statistical Computing, 2019); https://www.R-project.org/."},{"title3":"Solving differential equations in R: Package deSolve."}]}]},{"title1":"Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range","References":[{"title2":"A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction","References":[]},{"title2":"Comparison of systematic and narrative reviews: the example of the atypical antipsychotics","References":[]},{"title2":"Estimating the mean and variance from the median, range, and the size of a sample","References":[{"title3":"Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology"},{"title3":"Erythropoietin for patients with malignant disease. "},{"title3":"Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials: Comparison of Protocols to Published Articles"},{"title3":"Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia"},{"title3":"Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer"},{"title3":"Recombinant Human Erythropoietin and Platinum-Based Chemotherapy In Advanced Ovarian Cancer"},{"title3":"Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer."}]},{"title2":"Expected values of normal order statistics","References":[]},{"title2":"Estimating mean and standard deviation from the sample size, three quartiles, minimum, and maximum","References":[]},{"title2":"Association between c-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis","References":[]},{"title2":"Sputum myeloperoxidase in chronic obstructive pulmonary disease","References":[]},{"title2":"The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2288/14/135/prepub","References":[]}]},{"title1":"Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City","References":[{"title2":"Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy","References":[{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation."},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy."},{"title3":" home page ()."}]},{"title2":"Mortality associated with influenza and respiratory syncytial virus in the United States","References":[{"title3":"Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000"},{"title3":"Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009-2019: A Study of the National (Nationwide) Inpatient Sample"},{"title3":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study"},{"title3":"Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review"},{"title3":"Recommendations for prevention and control of influenza in children, 2021-2022"},{"title3":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)"},{"title3":"Mortality associated with influenza and respiratory syncytial virus in the US, 1999-2018"},{"title3":" . Seasonal flu vaccines. https://www.cdc.gov/flu/prevent/flushot.htm. Accessed 11 March 2022."},{"title3":"Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection"},{"title3":"Estimated burden of community-onset respiratory syncytial virus-associated hospitalizations among children aged &lt;2 years in the United States, 2014-15"},{"title3":"Trends in respiratory syncytial virus and bronchiolitis hospitalization rates in high-risk infants in a United States nationally representative database, 1997-2012"},{"title3":"Respiratory syncytial virus hospitalization risk in the second year of life by specific congenital heart disease diagnoses"},{"title3":"Risk of respiratory syncytial virus hospitalization in the first and second years of life in pediatric patients with congenital heart disease"},{"title3":"Risk factors for bronchiolitis-associated deaths among infants in the United States"},{"title3":"Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality"},{"title3":"Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants"},{"title3":"Mortality among US infants and children under 5 years of age with respiratory syncytial virus and bronchiolitis: A systematic literature review"},{"title3":"Investigation of respiratory syncytial virus-associated deaths among US children aged &lt;2 years, 2004-2007"},{"title3":"Respiratory syncytial virus-associated deaths in the United States according to death certificate data, 2005 to 2016"},{"title3":"The use of death certificate data to characterize mortality associated with respiratory syncytial virus, unspecified bronchiolitis, and influenza in the United States, 1999-2018"},{"title3":"Mortality associated with influenza and respiratory syncytial virus in the United States"},{"title3":"The 2014-2015 national impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States"},{"title3":"Safety of nirsevimab for RSV in infants with heart or lung disease or prematurity"},{"title3":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants"},{"title3":"Infant mortality in the United States, 1915-2017: large social inequalities have persisted for over a century"}]},{"title2":"Influenza-associated hospitalizations in the United States","References":[]},{"title2":"Seasonal influenza infections and cardiovascular disease mortality","References":[{"title3":"Infectious burden and atherosclerosis: a clinical issue"},{"title3":"Influenza virus infection and risk of acute myocardial infarction"},{"title3":"Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review"},{"title3":"Myocardial dysfunction during H1N1 influenza infection"},{"title3":"Global burden of influenza as a cause of cardiopulmonary morbidity and mortality"},{"title3":"Cardiac findings during uncomplicated acute influenza in ambulatory adults"},{"title3":"The cardiovascular manifestations of influenza: a systematic review"},{"title3":"Role of acute infection in triggering acute coronary syndromes"},{"title3":"Influenza-associated hospitalizations in the United States"},{"title3":"Excess mortality from causes other than influenza and pneumonia during influenza epidemics"},{"title3":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects"},{"title3":"Influenza and the winter increase in mortality in the United States, 1959-1999"},{"title3":"Forecasting seasonal outbreaks of influenza"},{"title3":"Real-time influenza forecasts during the 2012-2013 season"},{"title3":"How many illnesses does one emergency department visit represent? using a population-based telephone survey to estimate the syndromic multiplier"},{"title3":"Improving the estimation of influenza-related mortality over a seasonal baseline"},{"title3":"Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study"},{"title3":"Recent respiratory infection and risk of cardiovascular disease: case-control study through a general practice database"},{"title3":"Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Recent respiratory infection and the risk of myocardial infarction"},{"title3":"Absolute humidity and the seasonal onset of influenza in the continental United States"},{"title3":"What weather variables are important in predicting heat-related mortality? a new application of statistical learning methods"},{"title3":"Effects of cold and hot temperature on dehydration: a mechanism of cardiovascular burden"},{"title3":"Estimates of deaths associated with seasonal influenza: United States, 1976-2007"},{"title3":"Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14"},{"title3":"Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010)"},{"title3":"Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic"},{"title3":"Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age"},{"title3":"Cardiovascular manifestations associated with influenza virus infection"},{"title3":"Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice"},{"title3":"Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide"},{"title3":"Association of influenza vaccination and reduced risk of recurrent myocardial infarction"},{"title3":"Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease"},{"title3":"Seasonal variations in coronary heart disease"},{"title3":"Seasonal variations in fibrinogen concentrations among elderly people"},{"title3":"Protein S declines during winter respiratory infections"},{"title3":"Plasma catecholamines and cardiovascular responses to cold and mental activity"},{"title3":"Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections"},{"title3":"An explanation for the seasonality of acute upper respiratory tract viral infections"},{"title3":"Effects of steam inhalation on nasal patency and nasal symptoms in patients with the common cold"},{"title3":"Local hyperthermia benefits natural and experimental common colds"},{"title3":"Syndromic surveillance in public health practice, New York City"},{"title3":"Mortality due to influenza in the United States: an annualized regression approach using multiple-cause mortality data"},{"title3":"During influenza season: all influenza-like illnesses are not due to influenza: dengue mimicking influenza"},{"title3":"Mortality associated with influenza and respiratory syncytial virus in the United States"},{"title3":"National and local influenza surveillance through Twitter: an analysis of the 2012-2013 influenza epidemic"}]},{"title2":"Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects","References":[]},{"title2":"Influenza and cardiovascular disease: is there a causal relationship?","References":[]},{"title2":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19): United States, February 12-March 16, 2020","References":[{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"}]},{"title2":"Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care","References":[]},{"title2":"Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa)","References":[]},{"title2":"Intra-arrest induction of hypothermia via large-volume ice-cold saline for sudden cardiac arrest: the New York City Project Hypothermia Experience","References":[]},{"title2":"Survival from prehospital cardiac arrest is critically dependent upon response time","References":[]},{"title2":"Early cardiac arrest in patients hospitalized with pneumonia: a report from the American Heart Association's Get With The Guidelines-Resuscitation Program","References":[]},{"title2":"Pulmonary embolism as a cause of cardiac arrest: presentation and outcome","References":[]},{"title2":"Pulseless electrical activity and unsuccessful out-of-hospital resuscitation: what is the cause of death?","References":[]},{"title2":"In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China","References":[{"title3":"World Health Organization. Novel Coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ [accessed 01.04.20]."},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Cardiac arrest and cardiopulmonary resuscitation outcome reports: update of the Utstein Resuscitation Registry Template for in-hospital cardiac arrest. A consensus report from a Task Force of the International Liaison Committee on Resuscitation"},{"title3":"Heart disease and stroke statistics - 2019 update: a report from the American Heart Association"},{"title3":"Temporal trends and hospital-level variation of in-hospital cardiac arrest incidence and outcomes in the Veterans Health Administration"},{"title3":"Incidence and outcome of adult in-hospital cardiac arrest in Beijing, China"},{"title3":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State"},{"title3":"The International Liaison Committee on Resuscitation - review of the last 25 years and vision for the future"},{"title3":"Part 1: Executive Summary 2010 American Heart Association Guidelines for cardiopulmonary resuscitation and emergency cardiovascular care"},{"title3":"Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19)"}]},{"title2":"Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection","References":[{"title3":"Spread of a novel influenza A (H1N1) virus via global airline transportation"},{"title3":"Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico"},{"title3":"Systemic cytokine responses in patients with influenza-associated encephalopathy"},{"title3":"Cytochrome c and tumor necrosis factor-alpha values in serum and cerebrospinal fluid of patients with influenza-associated encephalopathy"},{"title3":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia"},{"title3":"Monocyte chemoattractant protein 1 contributes to an adequate immune response in influenza pneumonia"},{"title3":"Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model"},{"title3":"Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans?"},{"title3":"Encephalitis and encephalopathy associated with an influenza epidemic in Japan"}]},{"title2":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","References":[]},{"title2":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","References":[{"title3":"A novel coronavirus from patients with pneumonia in China. 2019"},{"title3":"WHO declares COVID-19 a Pandemic"},{"title3":"cdc.gov/coronavirus/2019.ncov"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Novel coronavirus: from discovery to clinical diagnostics"},{"title3":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis"},{"title3":"Pathologic findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Histopathologic changes and SARS-Cov-2 immunostaining in the lung of a patient with COVID-19"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Covid-19 does not lead to a &quot;Typical&quot; acute respiratory distress syndrome"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"The role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome"},{"title3":"Use of C4d as a diagnostic adjunct in lung allograft biopsies"},{"title3":"Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis"},{"title3":"A pathological report of three COVID-19 cases by minimally invasive autopsies"},{"title3":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS"},{"title3":"Degos disease: a C5b-9/interferon-alpha-mediated endotheliopathy syndrome"},{"title3":"Insights into the pathogenesis of catastrophic antiphospholipid syndrome. A case report of relapsing catastrophic antiphospholipid syndrome and review of the literature on ischemic colitis"},{"title3":"Typical and atypical hemolytic uremic syndrome in the critically Ill"},{"title3":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults"},{"title3":"The effects of Eculizumab on the pathology of malignant atrophic papulosis"},{"title3":"Anovel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways"},{"title3":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro"},{"title3":"Hematologic parameters in patients with COVID-19 infection"},{"title3":"Covid-19 in critically ill patients in the Seattle region-case series"},{"title3":"An approach to the patient with retiform purpura"},{"title3":"Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis"},{"title3":"Terminal complement complex (C5b-9) in children with recurrent hemolytic uremic syndrome"},{"title3":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy"},{"title3":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms"},{"title3":"The lectin pathway of complement and rheumatic heart disease"},{"title3":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2"},{"title3":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein"},{"title3":"Be on target: strategies of targeting alternative and lectin pathway components in complement-mediated diseases"},{"title3":"Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension"},{"title3":"Complement activation in angiotensin II-induced organ damage"}]},{"title2":"Cardiovascular disease, drug therapy, and mortality in Covid-19","References":[]},{"title2":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","References":[{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study"},{"title3":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy"},{"title3":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients"},{"title3":"Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom"},{"title3":"Where do we stand with antithrombotic prophylaxis in patients with COVID-19?"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Thromboinflammation and the hypercoagulability of COVID-19"},{"title3":"Pulmonary embolism"}]},{"title2":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","References":[{"title3":"An interactive web-based dashboard to track COVID-19 in real time"},{"title3":"John Hopkins University. https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 (28 March 2020)."},{"title3":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan,"},{"title3":"Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]"},{"title3":"Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"Viral dynamics in mild and severe cases of COVID-19"},{"title3":"COVID-19 infection: the perspectives on immune responses"},{"title3":"Treatment of coronary microvascular dysfunction"},{"title3":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province"},{"title3":"TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"National Health Commission of the People's Republic of China. Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (http://kjfy.meetingchina.org/msite/news/show/cn/3337.html 2020."},{"title3":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application"},{"title3":"COVID-19 with spontaneous pneumomediastinum"},{"title3":"Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia"},{"title3":"COVID-19 Lombardy ICU Network. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China"},{"title3":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19):China, 2020"},{"title3":"Likelihood of survival of coronavirus disease 2019"},{"title3":"May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. European Society of Hypertension COVID-19 Task Force Review of Evidence"},{"title3":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19"},{"title3":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2"},{"title3":"Renin-angiotensin system blockers and the COVID-19 oandemic: at present there is no evidence to abandon renin-angiotensin system blockers"},{"title3":"[Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia]"},{"title3":"Hypokalemia and clinical implications in patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Immune mechanisms of hypertension"},{"title3":"Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide"},{"title3":"White blood cells and blood pressure: a Mendelian randomization study"},{"title3":"Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension"},{"title3":"COVID-19 and the cardiovascular system"},{"title3":"Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis"},{"title3":"Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery"},{"title3":"SARS-CoV-2: a potential novel etiology of fulminant myocarditis"},{"title3":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2"},{"title3":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms"},{"title3":"Update on myocarditis"},{"title3":"Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens"},{"title3":"Viral persistence in the myocardium is associated with progressive cardiac dysfunction"},{"title3":"Myocarditis in humans and in experimental animal models"},{"title3":"Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-alpha-reactive CD4 T cells in A/J mice"},{"title3":"Cardiac myosin-Th17 responses promote heart failure in human myocarditis"},{"title3":"Acute infection and myocardial infarction"},{"title3":"Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity"},{"title3":"CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db mice"},{"title3":"Exploring immune checkpoints as potential therapeutic targets in atherosclerosis"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"The many faces of myocardial ischaemia and angina"},{"title3":"Mechanical stretch on endothelial cells interconnects innate and adaptive immune response in hypertension"},{"title3":"Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms"},{"title3":"Endothelial function assessment in atherosclerosis: comparison of brachial artery flowmediated vasodilation and peripheral arterial tonometry"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Acute pulmonary embolism and COVID-19 pneumonia: a random association?"},{"title3":"Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology"},{"title3":"The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall"},{"title3":"FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome"},{"title3":"COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-/- mice"},{"title3":"Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients"},{"title3":"Testosterone to oestradiol ratio reflects systemic and plaque inflammation and predicts future cardiovascular events in men with severe atherosclerosis"},{"title3":"Associations between cardiovascular disease, cancer, and very low high-density lipoprotein cholesterol in the REasons for Geographical and Racial Differences in Stroke (REGARDS) study"},{"title3":"New dimensions in circadian clock function: the role of biological sex"},{"title3":"Interleukin 6 trans-signalling and risk of future cardiovascular events"},{"title3":"Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling"},{"title3":"Interleukin-6 trans-signalling and risk of future cardiovascular events: a new avenue for atheroprotection?"},{"title3":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update"},{"title3":"Discovery of IL-6 and development of anti-IL-6R antibody"},{"title3":"The cardiovascular complications of chimeric antigen receptor T cell therapy"},{"title3":"CD1d-dependent natural killer T cells attenuate angiotensin II-induced cardiac remodeling via IL-10 signaling in mice"},{"title3":"The mineralocorticoid receptor as a modulator of innate immunity and atherosclerosis"},{"title3":"Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content"},{"title3":"IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis"},{"title3":"IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes"},{"title3":"Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kruppel-like factor 2"},{"title3":"Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol"},{"title3":"Interleukin-6 exacerbates early atherosclerosis in mice"},{"title3":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice"},{"title3":"The role of IL-6 in pathogenesis of abdominal aortic aneurysm in mice"},{"title3":"Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis"},{"title3":"Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension"},{"title3":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a Mendelian randomisation analysis"},{"title3":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies"},{"title3":"When, where, and how to target vascular inflammation in the post-CANTOS era?"},{"title3":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus"},{"title3":"Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells"},{"title3":"Immunolocalization of ACE2 and AT2 receptors in rabbit atherosclerotic plaques"},{"title3":"Deficiency of ACE2 in bone-marrow-derived cells increases expression of TNF-alpha in adipose stromal cells and augments glucose intolerance in obese C57BL/6 mice"},{"title3":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study"},{"title3":"Cardiovascular complications of severe acute respiratory syndrome"},{"title3":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS"},{"title3":"Vascular smooth muscle contraction in hypertension"},{"title3":"Smooth muscle cell and arterial aging: basic and clinical aspects"},{"title3":"Myocardial infarction increases ACE2 expression in rat and humans"},{"title3":"ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction"},{"title3":"Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city, Zhejiang,"},{"title3":"Elevation of ADAM10, ADAM17, MMP-2 and MMP-9 expression with media degeneration features CaCl2-induced thoracic aortic aneurysm in a rat model"},{"title3":"Randomised controlled trial begins for Ebola therapeutics"},{"title3":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro"},{"title3":"Approaches to the treatment of disease induced by chikungunya virus"},{"title3":"Interferon-Beta improves survival in enterovirus-associated cardiomyopathy"},{"title3":"Treatment options in myocarditis and inflammatory cardiomyopathy: focus on i.v. immunoglobulins"},{"title3":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature"},{"title3":"Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study"},{"title3":"Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial"},{"title3":"Temporal echocardiography findings in patients with fulminant myocarditis: beyond ejection fraction decline"},{"title3":"ESC e-Cardiology Working Group Position Paper: overcoming challenges in digital health implementation in cardiovascular medicine"},{"title3":"Perceived social isolation and cognition"},{"title3":"Social isolation induces Rac1-dependent forgetting of social memory"},{"title3":"Dorsal Raphe dopamine neurons represent the experience of social isolation"},{"title3":"Cognitive problems among breast cancer survivors: loneliness enhances risk"},{"title3":"Does loneliness mediate the relation between social support and cognitive functioning in later life?"},{"title3":"Social isolation affects the development of obesity and type 2 diabetes in mice"},{"title3":"Chronic social isolation is associated with metabolic gene expression changes specific to mammary adipose tissue"},{"title3":"Loneliness and the metabolic syndrome in a population-based sample of middle-aged and older adults"},{"title3":"Loneliness predicts postprandial ghrelin and hunger in women"},{"title3":"Restraint and social isolation stressors differentially regulate adaptive immunity and tumor angiogenesis in a breast cancer mouse model"},{"title3":"Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients"},{"title3":"Loneliness and pathways to disease"},{"title3":"Contrasting mechanisms by which social isolation and restraint impair healing in male mice"},{"title3":"Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation"},{"title3":"Stress and cardiovascular disease: an update on current knowledge"},{"title3":"An overview of systematic reviews on the public health consequences of social isolation and loneliness"},{"title3":"The impact of perceived and objective social isolation on hospital readmission in patients with heart failure: a systematic review and meta-analysis of observational studies"},{"title3":"Social isolation: a predictor of mortality comparable to traditional clinical risk factors"},{"title3":"Women, loneliness, and incident coronary heart disease"},{"title3":"Genetic risk for major depressive disorder and loneliness in sex-specific associations with coronary artery disease"},{"title3":"Loneliness, social isolation, and cardiovascular health"},{"title3":"Loneliness, social isolation and risk of cardiovascular disease in the English Longitudinal Study of Ageing"},{"title3":"Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy"},{"title3":"Social isolation and cardiovascular disease: an atherosclerotic pathway?"},{"title3":"Loneliness and social isolation as risk factors for coronary heart disease and stroke: systematic review and meta-analysis of longitudinal observational studies"},{"title3":"Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women"},{"title3":"Social deprivation and the HPA axis in early development"},{"title3":"The neuroendocrinology of social isolation"},{"title3":"Social isolation and diurnal cortisol patterns in an ageing cohort"},{"title3":"Effects of social isolation on glucocorticoid regulation in social mammals"},{"title3":"Cardiovascular control is associated with pair-bond success in male prairie voles"},{"title3":"Hormonal changes during long-term isolation"},{"title3":"Social effects and circadian rhythms in squirrel monkey pituitary-adrenal activity"},{"title3":"European isolation and confinement study. Workload and stress: effects on psychosomatic and psychobiological reaction patterns"},{"title3":"Subjective social status and inflammatory gene expression"},{"title3":"Neurobiology and consequences of social isolation stress in animal model:a comprehensive review"},{"title3":"Social isolation stress reduces hippocampal long-term potentiation: effect of animal strain and involvement of glucocorticoid receptors"},{"title3":"Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons"},{"title3":"COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel"},{"title3":"Presenting characteristics, Comorbidities, and outcomes among 5700 patients hospitalized With COVID-19 in the New York City area"}]},{"title2":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure","References":[{"title3":"Middle East respiratory syndrome virus pathogenesis"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients"},{"title3":"Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation"},{"title3":"Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases [in Chinese]"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"}]},{"title2":"Thromboinflammation and the hypercoagulability of COVID-19","References":[{"title3":"Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia"},{"title3":"Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia"},{"title3":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"},{"title3":"Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients* Multicenter Study; Randomized Controlled Trial"},{"title3":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia"},{"title3":"Racial differences in venous thromboembolism"},{"title3":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity"},{"title3":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence Based Clinical Practice Guidelines. American College of Chest Physicians"}]},{"title2":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019: COVID-NET, 14 states, March 1-30, 2020","References":[{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"The US Influenza Hospitalization Surveillance Network."},{"title3":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 : United States, February 12-March 28, 2020."},{"title3":"Estimating influenza disease burden from population-based surveillance data in the United States."}]},{"title2":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","References":[{"title3":"The novel coronavirus originating in Wuhan, China: challenges for global health governance"},{"title3":"Severe acute respiratory syndrome-related coronavirus: the species and its viruses:a statement of the Coronavirus Study Group"},{"title3":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"KDIGO clinical practice guidelines for acute kidney injury"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"},{"title3":"Chinese management guideline for COVID-19 (version 6.0)"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Middle East respiratory syndrome"},{"title3":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong"},{"title3":"Predictors of mortality in Middle East respiratory syndrome (MERS)"},{"title3":"Exacerbated innate host response to SARS-CoV in aged non-human primates"},{"title3":"The immunopathogenesis of sepsis in elderly patients"},{"title3":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)"},{"title3":"Serial evaluation of the SOFA score to predict outcome in critically ill patients"},{"title3":"Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network"},{"title3":"Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study"},{"title3":"Acute pneumonia and the cardiovascular system"},{"title3":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis"},{"title3":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004-2015"},{"title3":"Prevalence and significance of coagulation abnormalities in community-acquired pneumonia"},{"title3":"D-dimer is a significant prognostic factor in patients with suspected infection and sepsis"},{"title3":"Risk of myocardial infarction and stroke after acute infection or vaccination"},{"title3":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality"},{"title3":"Cardiovascular complications of acute respiratory infections: current research and future directions"},{"title3":"Regulation of ACE2 in cardiac myocytes and fibroblasts"},{"title3":"ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase"},{"title3":"Viral shedding and antibody response in 37 patients with Middle East Respiratory Syndrome coronavirus infection"},{"title3":"Viral load kinetics of MERS coronavirus infection"},{"title3":"Factors associated with prolonged viral shedding in patients with avian influenza A(H7N9) virus infection"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"}]},{"title2":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","References":[]},{"title2":"Heart disease and stroke statistics:2020 update: a report from the American Heart Association","References":[]},{"title2":"Ethnicity and COVID-19: an urgent public health research priority","References":[{"title3":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention"},{"title3":"&quot;Race&quot; and &quot;ethnicity&quot; in biomedical research: How do scientists construct and explain differences in health?"},{"title3":"Ethnicity, deprivation and mortality due to 2009 pandemic influenza A(H1N1) in England during the 2009/2010 pandemic and the first post-pandemic season"},{"title3":"UK government urged to investigate coronavirus deaths of BAME doctors"},{"title3":"Coronavirus cases to be tracked by ethnicity"},{"title3":"The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans"}]},{"title2":"Admissions to Veterans Affairs hospitals for emergency conditions during the COVID-19 pandemic","References":[]},{"title2":"Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy","References":[{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin."},{"title3":"COVID-19 in Europe: the Italian lesson."},{"title3":"Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response."},{"title3":"Government of Italy decree of the president of the Council of Ministers 9 March 2020 (). (In Italian.)"},{"title3":"L'andamento dei decessi del 2020. Dati anticipatori sulla base del sistema ANPR. Istat, March 31, 2020 (). (In Italian.)"}]},{"title2":"Advanced cardiac life support in out-of-hospital cardiac arrest","References":[{"title3":"Gender disparities in the application of public-access AED pads among OHCA patients in public locations."},{"title3":"Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association"},{"title3":"Main outcomes of the sudden cardiac arrest survey 2006 to 2016."},{"title3":"Public-access defibrillation and survival after out-of-hospital cardiac arrest"},{"title3":"Dispatcher-assisted cardiopulmonary resuscitation and survival in cardiac arrest"},{"title3":"Primary percutaneous coronary intervention and mild induced hypothermia in comatose survivors of ventricular fibrillation with ST-elevation acute myocardial infarction."},{"title3":"Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia"},{"title3":"Outcomes after out-of-hospital cardiac arrest treated by basic vs advanced life support"},{"title3":"A randomized trial of epinephrine in out-of-hospital cardiac arrest"},{"title3":"Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest"},{"title3":"Vasopressors during adult cardiac arrest: a systematic review and meta-analysis."},{"title3":"Effectiveness of prehospital epinephrine administration in improving long-term outcomes of witnessed out-of-hospital cardiac arrest patients with initial non-shockable rhythms."},{"title3":"Effect of a strategy of a supraglottic airway device vs tracheal intubation during out-of-hospital cardiac arrest on functional outcome: the AIRWAYS-2 randomized clinical trial"},{"title3":"Effect of a strategy of initial laryngeal tube insertion vs endotracheal intubation on 72-hour survival in adults with out-of-hospital cardiac arrest: a randomized clinical trial"},{"title3":"Pre-hospital advanced airway management for adults with out-of-hospital cardiac arrest: nationwide cohort study"},{"title3":"Advanced cardiac life support in out-of-hospital cardiac arrest"},{"title3":"Outcomes from out-of-hospital cardiac arrest in Metropolitan Taipei: does an advanced life support service make a difference?"},{"title3":"Effects of advanced life support on patients who suffered cardiac arrest outside of hospital and were defibrillated."},{"title3":"Part 3: adult basic and advanced life support: 2020 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care."},{"title3":"Association of timing of epinephrine administration with outcomes in adults with out-of-hospital cardiac arrest"},{"title3":"Prehospital Advanced Cardiac Life Support for Out-of-hospital Cardiac Arrest: A Cohort Study."},{"title3":"Duration of Prehospital Resuscitation Efforts After Out-of-Hospital Cardiac Arrest"},{"title3":"Time of on-scene resuscitation in out of-hospital cardiac arrest patients transported without return of spontaneous circulation"},{"title3":"Time to return of spontaneous circulation and survival: when to transport in out-of-hospital cardiac arrest?"},{"title3":"Association between Survival and Time of On-Scene Resuscitation in Refractory Out-of-Hospital Cardiac Arrest: A Cross-Sectional Retrospective Study."},{"title3":"Optimal Scene Time to Achieve Favorable Outcomes in Out-of-hospital Cardiac Arrest: How Long Is Too Long?"},{"title3":"Scene time interval and good neurological recovery in out-of-hospital cardiac arrest."},{"title3":"Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial."},{"title3":"Extracorporeal cardiopulmonary resuscitation in adults. Interim guideline consensus statement from the extracorporeal life support organization."},{"title3":"Endotracheal intubation during out-of-hospital cardiac arrest: New insights from recent clinical trials."},{"title3":"Interruptions in cardiopulmonary resuscitation from paramedic endotracheal intubation"},{"title3":"Advanced cardiac life support before and after tracheal intubation:direct measurements of quality."},{"title3":"How much experience do rescuers require to achieve successful tracheal intubation during cardiopulmonary resuscitation?"},{"title3":"Out-of-hospital endotracheal intubation experience, confidence and confidence-associated factors among Northern Japanese emergency life-saving technicians: a population-based cross-sectional study"},{"title3":"Mechanical versus manual chest compressions for out-of-hospital cardiac arrest: a meta-analysis of randomized controlled trials."},{"title3":"Quality of cardiopulmonary resuscitation in out-of-hospital cardiac arrest before and after introduction of a mechanical chest compression device, LUCAS-2; a prospective, observational study"}]},{"title2":"Outcomes after out-of-hospital cardiac arrest treated by basic vs advanced life support","References":[]},{"title2":"Outcomes after out-of-hospital cardiac arrest treated by basic vs advanced life support","References":[]},{"title2":"Advanced vs basic life support in the treatment of out-of-hospital cardiopulmonary arrest in the Resuscitation Outcomes Consortium","References":[]},{"title2":"Endotracheal intubation versus supraglottic airway placement in out-of-hospital cardiac arrest: a meta-analysis","References":[]},{"title2":"Airway management and out-of-hospital cardiac arrest outcome in the CARES registry","References":[]},{"title2":"Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City","References":[]}]},{"title1":"Out-of-hospital cardiac arrest during the COVID-19 pandemic in the Province of Padua, Northeast Italy","References":[{"title2":"Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy","References":[{"title3":"Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation."},{"title3":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease."},{"title3":"Clinical characteristics of coronavirus disease 2019 in China."},{"title3":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy."},{"title3":" home page ()."}]},{"title2":"Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study","References":[{"title3":"SARS-CoV-2 is an appropriate name for the new coronavirus"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Coronavirus (COVID-19) events as they happen"},{"title3":"COVID-19 map. Johns Hopkins Coronavirus Resource Centre"},{"title3":"The untold toll:the pandemic's effects on patients without Covid-19"},{"title3":"Out-of-hospital cardiac arrest during the Covid-19 outbreak in Italy"},{"title3":"COVID-19 deaths in Lombardy, Italy: data in context"},{"title3":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies"},{"title3":"Characteristics and prognosis of sudden cardiac death in Greater Paris: population-based approach from the Paris Sudden Death Expertise Center (Paris-SDEC)"},{"title3":"Early identification of patients with out-of-hospital cardiac arrest with no chance of survival and consideration for organ donation"},{"title3":"Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation"},{"title3":"DEFI 2005: a randomized controlled trial of the effect of automated external defibrillator cardiopulmonary resuscitation protocol on outcome from out-of-hospital cardiac arrest"},{"title3":"Population movement and sudden cardiac arrest location"},{"title3":"Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa)"},{"title3":"The variety of cardiovascular presentations of COVID-19"},{"title3":"Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"},{"title3":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19"},{"title3":"Mental health and the Covid-19 pandemic"},{"title3":"Cardiopulmonary resuscitation during the COVID-19 pandemic: a view from trainees on the frontline"},{"title3":"Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest"},{"title3":"Ventricular tachyarrhythmias after cardiac arrest in public versus at home"},{"title3":"Public-access defibrillation and neurological outcomes in patients with out-of-hospital cardiac arrest in Japan: a population-based cohort study"},{"title3":"Disparities in bystander cardiopulmonary resuscitation performed by a family member and a non-family member"}]},{"title2":"The other side of novel coronavirus outbreak: fear of performing cardiopulmonary resuscitation","References":[{"title3":"Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis"},{"title3":"Chung F. Bystanders 'feared coronavirus' after man collapsed outside Chinatown restaurant. (Retrieved 09 February 2020, at https://www.news.com.au/lifestyle/health/health-problems/bystanders-feared-coronavirus-after-man-collapsed-outside-chinatown-restaurant/news-story/4b1c6810fd911ec3f4f2b568b3695e10)."},{"title3":"Resuscitation Council UK Statement on COVID-19 in relation to CPR and resuscitation in first aid and community settings. (Retrieved 15 March 15 2020, at https://www.resus.org.uk/media/statements/resuscitation-council-uk-statements-on-covid-19-coronavirus-cpr-and-resuscitation/covid-community/)."},{"title3":"Adult basic life support and automated external defibrillation section Collaborators. European Resuscitation Council Guidelines for Resuscitation 2015: section 2. Adult basic life support and automated external defibrillation"},{"title3":"2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations: summary from the basic life support; advanced life support; pediatric life support; neonatal life support; education, implementation, and teams; and first aid task forces"}]},{"title2":"Prevalence of COVID-19 in out-of-hospital cardiac arrest: implications for bystander CPR","References":[]},{"title2":"COVID-19 - Mobility Trends Reports - Apple. (Accessed 16 June 2020, at https://www.apple.com/covid19/mobility/).","References":[]}]}]}